Breaking News Instant updates and real-time market news.

ONCE

Spark Therapeutics

07:07
10/13/17
10/13
07:07
10/13/17
07:07

Spark shares will continue to rise into 2018, says Jefferies

After hosting a "fireside chat" with the company and an FDA panel's unanimous vote in favor of Luxturna approval, Jefferies analyst Michael Yee says he believes shares of Spark Therapeutics will continue to go up into 2018. The analyst expects a "fairly modest but steady" uptake of Luxturna upon approval given a rare disease and limited centers to start. He believes his 2018 U.S. sales range of $40M-$50M is "theoretically doable." Yee keeps a Buy rating on Spark with a $95 price target.

  • 23

    Oct

  • 06

    Nov

  • 12

    Jan

ONCE Spark Therapeutics

10/12/17
RAJA
10/12/17
INITIATION
Target $96
RAJA
Outperform
Spark Therapeutics initiated with an Outperform at Raymond James
Raymond James analyst Reni Benjamin initiated Spark Therapeutics (ONCE) with an Outperform and $96 price target given expectations for LUXTURNA approval in 2018, encouraging clinical data seen with the hemophilia A program, a top partner in Pfizer (PFE) driving development in hemophilia B, and a platform technology to address large areas of unmet need.
10/10/17
JEFF
10/10/17
NO CHANGE
JEFF
Buy
Spark Therapeutics briefing documents look positive, says Jefferies
Jefferies analyst Michael Yee believes the FDA advisory committee briefing document and questions posted ahead of a panel review of Spark Therapeutics' blindness gene therapy drug look "fairly benign and as expected," which he thinks the market will view as a positive. Yee, who thinks the panel is likely to vote in favor of FDA approval on Thursday, keeps a Buy rating on Spark Therapeutics, which is up fractionally in early trading at $86 per share.
10/06/17
GSCO
10/06/17
INITIATION
Target $111
GSCO
Buy
Spark Therapeutics resumed with a Buy at Goldman Sachs
Goldman analyst Salveen Richter resumed coverage on Spark Therapeutics with a Buy and $111 price target.
09/21/17
JEFF
09/21/17
NO CHANGE
Target $95
JEFF
Buy
Jefferies sees Spark rallying 5%-7% on positive FDA panel
Jefferies analyst Michael Yee sees a "high likelihood" for a positive FDA panel on October 12 for Spark Therapeutics' SPK-RPE65, setting up approval for the first gene therapy drug for rare blindness on or before the FDA action date of January 12, 2018. The analyst sees 5%-7% share upside on a positive vote, mostly as a "de-risking event and also a positive read-through derivative to gene therapy companies as FDA starts to approve gene therapy drugs." He keeps a Buy rating on Spark with a $95 price target.

TODAY'S FREE FLY STORIES

NEM

Newmont Mining

$38.16

-0.23 (-0.60%)

, HRL

Hormel Foods

$32.68

-1.12 (-3.31%)

20:25
02/21/18
02/21
20:25
02/21/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

NEM

Newmont Mining

$38.16

-0.23 (-0.60%)

HRL

Hormel Foods

$32.68

-1.12 (-3.31%)

APA

Apache

$37.20

-1.1 (-2.87%)

LDOS

Leidos

$65.21

-1.02 (-1.54%)

W

Wayfair

$95.69

-0.61 (-0.63%)

OA

Orbital ATK

$131.80

-0.02 (-0.02%)

TREE

LendingTree

$371.25

-7.8 (-2.06%)

SFM

Sprouts Farmers Market

$26.12

0.12 (0.46%)

TPX

Tempur Sealy

$54.97

1.17 (2.17%)

SAFM

Sanderson Farms

$128.00

-3.44 (-2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 08

    Mar

  • 20

    Mar

  • 29

    Mar

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

20:04
02/21/18
02/21
20:04
02/21/18
20:04
Syndicate
Aimmune 5.5M share Secondary priced at $32.00 »

BofA/Merrill, Cantor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 11

    Mar

  • 22

    Feb

20:00
02/21/18
02/21
20:00
02/21/18
20:00
General news
Breaking General news story  »

Minneapolis Federal…

NUAN

Nuance

$16.28

-0.28 (-1.69%)

19:10
02/21/18
02/21
19:10
02/21/18
19:10
Periodicals
Nuance discontinues Swype feature development, Verge reports »

Nuance has ceased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

SSNLF

Samsung

, QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

19:04
02/21/18
02/21
19:04
02/21/18
19:04
Hot Stocks
Samsung, Qualcomm expand foundry cooperation on EUV process technology »

Samsung Electronics…

SSNLF

Samsung

QCOM

Qualcomm

$63.40

-0.59 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 06

    Mar

CATY

Cathay General

$42.84

0.43 (1.01%)

18:59
02/21/18
02/21
18:59
02/21/18
18:59
Hot Stocks
Cathay General executive chairman Cheng sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUN

Sunoco

$30.00

-0.08 (-0.27%)

18:42
02/21/18
02/21
18:42
02/21/18
18:42
Earnings
Sunoco reports Q4 EPS $2.01, may not compare to consensus 35c »

Reports Q4 revenue $3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

USFD

US Foods

$32.29

0.33 (1.03%)

18:39
02/21/18
02/21
18:39
02/21/18
18:39
Hot Stocks
US Foods director Lederer sells 98,702 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLRS

Volaris

$9.14

0.12 (1.33%)

18:38
02/21/18
02/21
18:38
02/21/18
18:38
Earnings
Volaris reports Q4 28c, consensus 20c »

Reports Q4 revenue $336M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLRS

Volaris

$9.14

0.12 (1.33%)

18:34
02/21/18
02/21
18:34
02/21/18
18:34
Earnings
Breaking Earnings news story on Volaris »

Volaris reports Q4 net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMI

Valmont

$156.55

-0.55 (-0.35%)

18:29
02/21/18
02/21
18:29
02/21/18
18:29
Earnings
Valmont sees 2018 adjusted $8.00, consensus $8.15 »

Sees 2018 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 06

    Mar

VMI

Valmont

$156.55

-0.55 (-0.35%)

18:27
02/21/18
02/21
18:27
02/21/18
18:27
Earnings
Valmont reports Q4 adjusted EPS $1.67, consensus $1.69 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 06

    Mar

CTRV

ContraVir Pharmaceuticals

$0.25

-0.013 (-5.00%)

18:11
02/21/18
02/21
18:11
02/21/18
18:11
Hot Stocks
ContraVir Pharmaceuticals' hepatitis B treatment receives FDA Orphan designation »

ContraVir…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

AAC

AAC Holdings

$8.38

0.25 (3.08%)

18:06
02/21/18
02/21
18:06
02/21/18
18:06
Earnings
AAC Holdings sees FY18 adjusted EPS 70c-75c, consensus 53c »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AAC

AAC Holdings

$8.38

0.25 (3.08%)

18:05
02/21/18
02/21
18:05
02/21/18
18:05
Earnings
AAC Holdings reports Q4 adjusted EPS 10c, consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

DNKN

Dunkin' Brands

$60.70

-1.45 (-2.33%)

18:04
02/21/18
02/21
18:04
02/21/18
18:04
Hot Stocks
Baskin-Robbins expands in Toronto with plans for four new locations »

Baskin-Robbins, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$102.43

0.05 (0.05%)

18:01
02/21/18
02/21
18:01
02/21/18
18:01
Hot Stocks
Celanese to increase price of acetyl intermediate products »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 30

    May

TUSK

Mammoth Energy

$20.04

-0.11 (-0.55%)

17:56
02/21/18
02/21
17:56
02/21/18
17:56
Earnings
Mammoth Energy reports Q4 EPS $1.48, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

NSPR

InspireMD

$4.20

-0.26 (-5.83%)

17:53
02/21/18
02/21
17:53
02/21/18
17:53
Syndicate
Breaking Syndicate news story on InspireMD »

InspireMD files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

$51.76

-0.25 (-0.48%)

17:52
02/21/18
02/21
17:52
02/21/18
17:52
Syndicate
Breaking Syndicate news story on E-Trade »

E-Trade files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAVE

Spirit Airlines

$39.91

1.01 (2.60%)

17:47
02/21/18
02/21
17:47
02/21/18
17:47
Syndicate
Breaking Syndicate news story on Spirit Airlines »

Spirit Airlines files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAND

Bandwidth

$24.09

0.18 (0.75%)

, CAR

Avis Budget

$38.96

-0.98 (-2.45%)

17:42
02/21/18
02/21
17:42
02/21/18
17:42
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

BAND

Bandwidth

$24.09

0.18 (0.75%)

CAR

Avis Budget

$38.96

-0.98 (-2.45%)

MB

Mindbody

$33.35

-0.1 (-0.30%)

SAIL

SailPoint Technologies

$17.92

0.47 (2.69%)

STMP

Stamps.com

$184.95

-5.1 (-2.68%)

GPOR

Gulfport Energy

$8.41

-0.32 (-3.67%)

SNPS

Synopsys

$88.46

-1.3 (-1.45%)

PE

Parsley Energy

$23.10

-0.19 (-0.82%)

P

Pandora

$4.87

-0.46 (-8.63%)

MLNX

Mellanox

ROKU

Roku

$51.10

-0.08 (-0.16%)

AAOI

Applied Optoelectronics

$34.55

1.22 (3.66%)

SRCL

Stericycle

$74.91

-0.31 (-0.41%)

CSLT

Castlight Health

$3.85

0.3 (8.45%)

UCTT

Ultra Clean

$19.96

-0.4 (-1.96%)

TRN

Trinity Industries

$35.23

0.47 (1.35%)

RGR

Sturm, Ruger

$47.30

-1.05 (-2.17%)

CONE

CyrusOne

$48.81

-1.56 (-3.10%)

ADXS

Advaxis

$2.51

-0.08 (-3.09%)

GWPH

GW Pharmaceuticals

$132.33

1.5 (1.15%)

OMF

OneMain Holdings

$31.67

-0.22 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 22

    Feb

  • 23

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 05

    Mar

  • 11

    Mar

  • 13

    Mar

  • 14

    Mar

  • 21

    Mar

  • 26

    Mar

  • 28

    Mar

  • 29

    Mar

  • 03

    Apr

  • 15

    May

  • 23

    May

  • 27

    Jun

  • 22

    Feb

CLI

Mack-Cali Realty

$18.33

-0.25 (-1.35%)

17:40
02/21/18
02/21
17:40
02/21/18
17:40
Earnings
Breaking Earnings news story on Mack-Cali Realty »

Mack-Cali Realty sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLI

Mack-Cali Realty

$18.33

-0.25 (-1.35%)

17:39
02/21/18
02/21
17:39
02/21/18
17:39
Earnings
Breaking Earnings news story on Mack-Cali Realty »

Mack-Cali Realty reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIC

Macquarie Infrastructure

$63.62

-0.75 (-1.17%)

17:32
02/21/18
02/21
17:32
02/21/18
17:32
Hot Stocks
Macquarie Infrastructure to reduce 2018 dividend to help fund asset repurposing »

Macquarie Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.